Skip to main content
Watch Insiders
SYREHealthcare

Spyre Therapeutics Inc. (SYRE) Insider Trading

In the last 90 days, 4 Spyre Therapeutics Inc. (SYRE) insiders reported no open-market purchases and 9 sales totaling $16,903,261. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Heidy King-JonesSee RemarksSale28,933$91.03$2,633,901
Oct 1, 2026Cameron TurtleChief Executive OfficerSale15,000$92.01$1,380,105
Oct 1, 2026Scott L BurrowsChief Financial OfficerSale25,000$90.47$2,261,830
Sep 2, 2026Heidy King-JonesSee RemarksSale28,399$87.35$2,480,528
Sep 2, 2026Scott L BurrowsChief Financial OfficerSale25,732$88.75$2,283,821
Sep 1, 2026Cameron TurtleChief Executive OfficerSale15,000$87.29$1,309,410
Aug 7, 2026Jeffrey W. AlbersCorporate insiderSale23,000$104.53$2,404,190
Aug 3, 2026Scott L BurrowsChief Financial OfficerSale7,500$95.57$716,771
Aug 3, 2026Cameron TurtleChief Executive OfficerSale15,000$95.51$1,432,706
Jul 1, 2026Scott L BurrowsChief Financial OfficerSale7,500$87.74$658,040
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

SYRE insider trading FAQ

Are SYRE insiders buying or selling?
Over the last 90 days, SYRE insiders were net sellers, reporting $0.00 of open-market purchases and $16,903,261 of sales.
When was the last SYRE insider purchase?
No open-market insider purchase of Spyre Therapeutics Inc. stock was reported in the last 90 days.
Where does SYRE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Spyre Therapeutics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.